Today marks a pivotal moment in Brain+'s journey to help people affected by dementia live better lives and as the Company transitions to build a commercial presence, starting in the UK as the most mature and attractive market for the company’s dementia care solutions. Centered around the UK market introduction of Ayla, the world's first scalable dementia care platform, the Company unveils a corporate rebranding. This strategic rebrand includes a new corporate visual identity and a new website to coincide with the recent Medical Device Software certification and subsequent commercial launch of the first Ayla Dementia Care flagship product, Ayla – your CST Assistant.

Ayla, meaning "bearer of light", embodies Brain+’ mission to help people affected by dementia, live better lives. Ayla is intended to be relatable, familiar and compassionate, providing a sense of hope, both to people with dementia and to their loved ones and family members who provide care and support. This powerful new brand name represents the commitment to nurture this hope by building the world's first scalable dementia care platform, designed to help people affected by dementia, enhancing the lives of individuals living with dementia and their caregivers.

The refreshed visual identity features a soothing, empathetic colour palette that will resonate across the entire Ayla Dementia Care product suite as it builds. The rebranding initiative reflects Brain+’ dedication to creating solutions that are not only clinically effective but also emotionally supportive and user-friendly and it sets the stage for the expansion of the Ayla Dementia Care platform. We're excited to announce that development is underway for Ayla – your Home Companion, scheduled for release alongside the platform in 2025. This new product will complement Ayla – your CST Assistant, providing comprehensive support for dementia patients both in clinical settings and at home.

With this rebranding, Brain+ is not just changing its look – the Company is reaffirming its position as a pioneer in digitally supported dementia care, committed to innovation, compassion, and transformative healthcare solutions

Invitation to clinical and commercial webinar

In line with Brain+’ previously released commercial roll-out plan and awareness campaign for Ayla – your CST Assistant in the UK, Brain+ is hosting a clinical webinar on 21 October 2024 under the title “Unlocking the value of Cognitive Stimulation Therapy (CST): A best kept secret”. In the webinar, leading dementia and CST experts will speak on the background and evidenced benefits of CST for people affected by dementia, and the offerings of Ayla – your CST Assistant as the only available solution to offer digital CST will be presented. For more information and to sign up for the webinar: LinkedIn: Invitation to Brain+ webinar on CST and Ayla – your CST Assistant 

Contact Information

CEO and Co-founder, Kim Baden-Kristensen: + 45 31 39 33 17 (SMS), kim@brain-plus.com

CCO, Devika Wood: + +44 742 928 03 66, devika@brain-plus.com

Brain+ vision:

Building the world’s first scalable dementia care platform to help people affected by dementia, live better lives